NYSEMKT: KNWKnow Labs Inc Stock
$0.40-0.01 (-2.44%)
Updated Apr 21, 2025
KNW Price
$0.40
Fair Value Price
N/A
Market Cap
$43.46M
52 Week Low
$0.08
52 Week High
$2.45
P/E
-2.01x
P/B
-20.15x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$16.58M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-2.7
Operating Cash Flow
-$13M
Beta
-10.92
Next Earnings
May 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A
KNW Overview
Know Labs, Inc., develops, markets, and sells proprietary technologies in the United States. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilize electromagnetic energy along the electromagnetic spectrum to perform analytics, which allow the user to identify, authenticate, and diagnose various organic and non-organic materials and substances. The company, through its subsidiary TransTech Systems, Inc., distributes products for employee and personnel identification and authentication. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine KNW's potential to beat the market
- KNW doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Scientific & Technical Instrument
Industry Rating
A
KNW
RankedUnranked of 24
RankedUnranked of 24
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $109.02 | A | |
| $23.92 | B | |
| $146.61 | B |
Be the first to know about important KNW news, forecast changes, insider trades & much more!
KNW News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KNW scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KNW is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KNW is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
KNW's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more KNW due diligence checks available for Premium users.
Valuation
KNW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.01x
Industry
18.85x
Market
27.14x
KNW price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-20.15x
Industry
2.82x
KNW's financial health
Profit margin
Revenue
$0.0
Net Income
-$3.6M
Profit Margin
0%
KNW's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$3.7M
Liabilities
$5.8M
Debt to equity
-2.7
KNW's short-term liabilities ($5.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KNW's short-term assets ($3.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KNW's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KNW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.3M
Investing
$0.0
Financing
$4.2M
KNW's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KNW vs Scientific & Technical Instrument Stocks
Know Labs Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.